Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Irinotecan in Metastatic Colorectal Cancer With K-RAS Mutation
NCT00989469Phase 2Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Feb 2009
- Primary completion
- Feb 2011
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in colorectal cancer (CRC), sponsored by Institut du Cancer de Montpellier. Started Feb 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00989469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989469.